Table 5.
WHO-5 scores and statistical tests.
| Group | Total (N) | WHO-5 raw score | SD | Below the threshold | Above the threshold | Total (%) | Statistic test | Statistical value | ||
|---|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | |||||||
| Gender | T-test (gender) | t = 1.89, df = 372, p = 0.059 | ||||||||
| M | 132 | 11.09 | 6.27 | 63 | 16.8% (30.1%) | 69 | 18.4% (41.8%) | 35.3% (100%) | ||
| F | 242 | 10.06 | 6.23 | 146 | 39.0% (69.9%) | 96 | 25.7% (58.2%) | 64.7% (100%) | ||
| Tot. | 374 | 11.01 | 6.27 | 209 | 55.9% (100%) | 165 | 44.1% (100%) | 100% | ||
| Age | ANOVA (age) | F = 3.31, df1 = 4, df2 = 134, p = 0.005* | ||||||||
| 70–79 | 57 | 10.07 | 6.28 | 34 | 9.1% (16.3%) | 23 | 6.1% (13.9%) | 15.2% (100%) | ||
| 60–69 | 139 | 11.42 | 6.27 | 70 | 18.7% (33.5%) | 69 | 18.4% (41.8%) | 37.1% (100%) | ||
| 50–59 | 101 | 11.18 | 5.98 | 58 | 15.5% (27.8%) | 43 | 11.5% (26.1%) | 27.0% (100%) | ||
| ≥ 80 | 42 | 8.74 | 5.93 | 34 | 9.1%, (16.3%) | 8 | 2.1% (4.8%) | 11.2% (100%) | ||
| Under 50 | 35 | 14.06 | 6.36 | 13 | 3.5% (6.2%) | 22 | 5.9% (13.3%) | 9.4% (100%) | ||
| Tot. | 374 | 11.01 | 6.27 | 209 | 55.9% (100%) | 165 | 44.1% (100%) | 100% | ||